The U.S. medical grade polypropylene market, valued at USD 1.09 billion in 2024, is poised for robust expansion at a CAGR of 6.9% from 2025 to 2034. This growth is underpinned by increasing application-specific demand across diverse healthcare segments, ranging from single-use devices to advanced diagnostic components. Polypropylene’s thermal stability, chemical inertness, and compatibility with sterilization processes position it as a highly differentiated polymer solution in medical applications. Segment-wise performance analysis reveals that disposable medical devices, pharmaceutical packaging, and laboratory consumable
Like
Comment
Share
